OMER has been in the news 900% more than usual
Nov 14, 2025, 1:32 PM
26.08%
What does OMER do
Omeros, a Seattle-based biopharmaceutical company with 198 employees, focuses on developing therapeutics for immunologic disorders and is advancing several candidates, including narsoplimab and OMS527, in clinical trials. The company went public on October 8, 2009.
OMER has been in the news recently: Omeros (NASDAQ:OMER) is scheduled to announce its quarterly earnings on November 13, 2025. Investors should pay attention to this announcement, as it coincides with other companies reporting earnings, including notable growth in revenue for some firms.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.